「president」の検索結果
20件：11～15件目を表示
もしかして
-
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designatio...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708.pdf -
ribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of t...
https://www.senju.co.jp/sites/default/files/content_news/2023-11/ENG__20231101.pdf -
ribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of t...
https://www.senju.co.jp/sites/default/files/content_news/2023-11/ENG__20231101_0.pdf -
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has started Phase III c...
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509.pdf -
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has started Phase III c...
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509_0.pdf